Cinacalcet HCl is indicated for the treatment of secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) on dialysis.

Products Name: Cinacalcet HCl
CAS NO.: 364782-34-3
Synonyms: N-((1R)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride
Formula: C22H22F3N.HCl
Weight: 393.88
Structure:

Cinacalcet HCl is indicated for the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease on dialysis.
Cinacalcet HCl is indicated for the treatment of hypercalcemia in patients with parathyroid carcinoma.
Cinacalcet HCl lowers serum calcium. Significant reductions in calcium may lower the threshold for seizures. Secondary hyperparathyroidism patients, particularly those with a history of a seizure disorder, should be carefully monitored for the occurrence of low serum calcium or symptoms of hypocalcemia. The most commonly reported side effects were nausea and vomiting.

Cinacalcet HCl is indicated for the treatment of secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) on dialysis.
HPT(hyperparathyroidism)
PTH(parathyrioidhomone)
(hypo-or adynamic bone disease,ABD)